Stay updated on LEGEND Clinical Trial: Lanifibranor and EmpaGliflozin in NASH with T2DM

Sign up to get notified when there's something new on the LEGEND Clinical Trial: Lanifibranor and EmpaGliflozin in NASH with T2DM page.
Latest website image capture
Clouds background image

Latest updates to the LEGEND Clinical Trial: Lanifibranor and EmpaGliflozin in NASH with T2DM page

  1. Check
    5 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer now displays revision v3.7.1 instead of v3.7.0.
    Difference
    0.1%
    Check dated 2026-10-11T14:08:04.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    A new revision tag v3.7.0 has been added, replacing the previous v3.6.6, indicating the page was updated to a newer software/version release.
    Difference
    0.1%
    Check dated 2026-09-20T19:48:23.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    The study history introduces a Results Posted entry and adds Outcome Measures (Results) and related Study Status updates, while removing the previous Results Submitted entry from 2024-07-09, reflecting that results are now available on the record.
    Difference
    1%
    Check dated 2026-09-13T17:27:56.000Z thumbnail image
  6. Check
    40 days ago
    Change Detected
    Summary
    The most recent version adds sections for Outcome Measures (Results), Document Section, Outcome Measures, and Study Status, and notes that the Quality Control Review Has Not Concluded. This indicates the latest submission includes results-related content and shows a pending QC status for the record.
    Difference
    0.6%
    Check dated 2026-09-06T12:14:31.000Z thumbnail image
  7. Check
    48 days ago
    Change Detected
    Summary
    A new version entry (22) dated 2026-08-24 is added to the study record history, introducing multiple expanded sections such as Returned, Quality Control Review Has Not Concluded, Limitations and Caveats, and Outcome Measures (Results), Baseline Characteristics, Participant Flow, and Study Design. The update also notes Revision: v3.6.6 and removes Revision: v3.6.5, reflecting an update to the record's documentation and structure.
    Difference
    1%
    Check dated 2026-08-30T06:20:53.000Z thumbnail image
  8. Check
    69 days ago
    Change Detected
    Summary
    A new revision entry v3.6.5 is added to the study's version history, and the previous revision v3.6.4 is removed from the visible history to update the audit trail.
    Difference
    0.1%
    Check dated 2026-08-08T23:21:45.000Z thumbnail image

Stay in the know with updates to LEGEND Clinical Trial: Lanifibranor and EmpaGliflozin in NASH with T2DM

Enter your email address, and we'll notify you when there's something new on the LEGEND Clinical Trial: Lanifibranor and EmpaGliflozin in NASH with T2DM page.